Using a combination of in silico analyses, genetic cellular studies, pharmacological approaches, and cardiomyocyte-specific knockout mice, we demonstrate that the upregulation of zDHHC4 in diabetes is mediated by activation of the FoxO1 transcription factor. The gene discussed is ZDHHC4; the disease is diabetes mellitus.